Combination of | |
---|---|
Insulin icodec | Insulin analog |
Semaglutide | GLP-1 receptor agonist |
Clinical data | |
Trade names | IcoSema |
Legal status | |
Legal status |
|
Insulin icodec/semaglutide, or IcoSema, is a combination medication of insulin icodec and semaglutide in development for type 2 diabetes by Novo Nordisk. It is injected once weekly. [1] [2] [3]